-
-
-
-
-
-
-
Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition
-
-
-
-
-
-
-
Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
Verrica Pharmaceuticals Inc. (VRCA) to Offer Common Stock
-
-
-
-
-
-
-
Verrica Pharmaceuticals Announces Participation in the Jefferies 2019 Healthcare Conference
-
-
-
-
-
-
-
Verrica Pharmaceuticals (VRCA) IPO Opens 33%
-
-
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

